CCO Infectious Disease Podcast

Key Decisions in HIV Care: Postexposure Prophylaxis

Episode Summary

Listen as Dr Michelle D. Collins-Ogle shares data and recommendations for HIV PEP, including currently recommended regimens, single-tablet regimens, and pre-exposure prophylaxis following PEP.

Episode Notes

In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores the data and recommendations for HIV postexposure prophylaxis (PEP).

Listen as she gives perspectives on:

• The CDC algorithm for evaluation and treatment of 
  potential HIV exposures
• The CDC guideline preferred and alternative PEP antiretroviral therapy regimens
• Data for the use of the single-tablet regimen bictegravir/emtricitabine/tenofovir alafenamide for PEP
• Recommended laboratory monitoring with PEP
• The initiation of pre-exposure prophylaxis following a course of PEP, when appropriate

Presenter:

Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS
Assistant Professor of Pediatrics
Division of Pediatric Infectious Diseases
Pediatric and Adolescent HIV 
Children’s Hospital at Montefiore
Pediatric Hospital of Albert Einstein 
College of Medicine
Bronx, New York 

Follow along with the slides at:
https://bit.ly/3NBVXWN

See the entire program at:
https://bit.ly/3fOl0XX